PDA

View Full Version : Positive Phase 2 Topline Results Show Novavax's COVID-Influenza Combination, Stand-alone Influenza and High-dose COVID Vaccine Candidates Demonstrate Robust Immune Responses - Novavax Investor Relations


news
05-09-2023, 02:30 PM
Positive Phase 2 Topline Results Show Novavax's COVID-Influenza Combination, Stand-alone Influenza and High-dose COVID Vaccine Candidates Demonstrate Robust Immune Responses (https://news.google.com/rss/articles/CBMizgFodHRwczovL2lyLm5vdmF2YXguY29tLzIwMjMtMDUtMD ktUG9zaXRpdmUtUGhhc2UtMi1Ub3BsaW5lLVJlc3VsdHMtU2hv dy1Ob3ZhdmF4cy1DT1ZJRC1JbmZsdWVuemEtQ29tYmluYXRpb2 4sLVN0YW5kLWFsb25lLUluZmx1ZW56YS1hbmQtSGlnaC1kb3Nl LUNPVklELVZhY2NpbmUtQ2FuZGlkYXRlcy1EZW1vbnN0cmF0ZS 1Sb2J1c3QtSW1tdW5lLVJlc3BvbnNlc9IBAA?oc=5) Novavax Investor RelationsView Full Coverage on Google News (https://news.google.com/stories/CAAqNggKIjBDQklTSGpvSmMzUnZjbmt0TXpZd1NoRUtEd2lCdz cyMkJ4SGhmdTJNNnRPS0RTZ0FQAQ?hl=en-US&gl=US&ceid=US:en&oc=5)

More... (https://news.google.com/rss/articles/CBMizgFodHRwczovL2lyLm5vdmF2YXguY29tLzIwMjMtMDUtMD ktUG9zaXRpdmUtUGhhc2UtMi1Ub3BsaW5lLVJlc3VsdHMtU2hv dy1Ob3ZhdmF4cy1DT1ZJRC1JbmZsdWVuemEtQ29tYmluYXRpb2 4sLVN0YW5kLWFsb25lLUluZmx1ZW56YS1hbmQtSGlnaC1kb3Nl LUNPVklELVZhY2NpbmUtQ2FuZGlkYXRlcy1EZW1vbnN0cmF0ZS 1Sb2J1c3QtSW1tdW5lLVJlc3BvbnNlc9IBAA?oc=5)